Cannabidiol dimethyl ether
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H34O2 |
Molar mass | 342.523 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Cannabidiol dimethyl ether (CBDD) is a trace component of cannabis which can also be made synthetically. It is a potent and selective inhibitor of the enzyme 15-lipoxygenase and inhibits oxygenation of linoleic acid, a process involved in the development of atherosclerosis.[1][2]
See also
- 4'-Fluorocannabidiol
- 7-Hydroxycannabidiol
- 8,9-Dihydrocannabidiol
- Cannabicitran
- Delta-6-Cannabidiol
- KLS-13019
- O-1918
References
- ↑ Takeda S, Usami N, Yamamoto I, Watanabe K (August 2009). "Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor". Drug Metabolism and Disposition. 37 (8): 1733–7. doi:10.1124/dmd.109.026930. PMID 19406952.
- ↑ Takeda S, Hirayama A, Urata S, Mano N, Fukagawa K, Imamura M, et al. "Cannabidiol-2',6'-dimethyl ether as an effective protector of 15-lipoxygenase-mediated low-density lipoprotein oxidation in vitro". Biological & Pharmaceutical Bulletin. 34 (8): 1252–6. doi:10.1248/bpb.34.1252. PMID 21804214.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.